New York Lindesmith Center Hear in RealAudio Sound quality is excellent except for the first few minutes, so be patient. Speakers: Julie Holland, MD, attending psychiatrist, Bellevue Hospital Psychiatric …
Investigators: Hermle L, Gouzoulis-Mayfrank E, Spitzer M Department of Psychiatry, Christophsbad, Goppingen, Germany. Abstract of published paper
A pilot study of MDMA therapy in the treatment of PTSD has been approved and will be the first formal therapy study with MDMA ever conducted. (Read current update) MAPS has pledged $54,000 for this study; …
Investigator: Jordi Cam, MD, Magi Farr, MD, et al. Institut Municipal d’Investigacio Medica – Barcelona, Spain Contact: Jordi Camí, MD or Magi Farré, MD Sponsor: Funded in part by …
Investigators: Charles S. Grob, MD, and Russell E. Poland, PhD Harbor-UCLA Medical Center – Torrance, California, USA Sponsor: MAPS, Harbor/UCLA Contact: , FDA-approved Phase 1 dose-response safety …
Investigator: John Henry, MD University College London, England Contact: This was a neurotoxicity study. Henry is directing additional MDMA studies at this time. Fallon JK, Kicman AT, Henry JA, Milligan …
Investigators: Marianne Bloch, MD, Jurai Styk, MD and Dr. Samuel Widmer, MD Sponsor: Swiss Medical Society for Psycholytic Therapy From 1988 to 1993 therapists with the Swiss Medical Society for Psycholytic …
Investigators: Alex Gamma, PhD, Franz Vollenweider, MD Psychiatric University Hospital – Zrich, Switzerland Sponsor: UBS Science Foundation and others Contact: Franz Vollenweider, MD, Alex Gamma …
August 30 - September 1, 1999. MAPS Conference on the Clinical Utility of MDMA and MDE (Dead Sea Conference). George Greer, MD. 56K: Clip 1 / Clip 2 28K: Clip 1 / Clip 2 Charles Grob, MD. 56K: Clip 1 / …
On September 1, 1999, Jordi Camí, MD, PhD, Magi Farré, MD, PhD, and José Carlos Bouso, PhD presented their Phase 1 clinical study of MDMA-assisted psychotherapy for PTSD at the MAPS MDMA …
MAPS organized an international symposium on the medical utility of MDMA. Talks from this event, held August 31 to September 1, 1999, are posted on this site (talks by George Greer, Juraj and Sonja Styk …
Teleconference with the FDA concerning MDMA psychotherapy research to treat anxiety, depression and pain in cancer patients, the FDA indicates a willingness to approve a “proof of principle” …
